North America Drug Delivery Systems Market Trends and Analysis by 2027
Historic Data: 2016-2017 | Base Year: 2018 | Forecast Period: 2019-2027North America Drug Delivery Systems Market to 2027- Regional Analysis and Forecasts By Route of Administration (Transmucosal, Oral, Injectable, Topical, Implantable, and Ocular); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies); and Application (Home Care Settings, Hospitals & Clinics, and Others), and Country
- Report Date : Jun 2019
- Report Code : TIPRE00005752
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 249
The North America human drug delivery systems market is expected to reach US$ 1,074,679.7 Mn in 2027 from US$ 572,453.0 Mn in 2018. The market is estimated to grow with a CAGR of 7.4% from 2019-2027.
Key factors that are driving the growth of the market are rising need for medication among the populace, extensive research and developments projects undertaken by various market players to sustain their leadership in the market leading to launch of new and innovative products as well as a well-established pharmaceutical and medical device industry in the region.
Over the past few decades, Research and development (R&D) in drug delivery devices is increasing across the globe due to the increasing prevalence of the chronic disease. Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans. Various routes of administration are being studied in order to treat these chronic diseases. According to the Centers for Disease Control and Prevention (CDC) in 2019, almost 6 in 10 people in the US suffer from at least one chronic disease and 4 in 10 people have two or more chronic diseases. Also, cancer is one of the leading cause of death in the North America region. Furthermore, the American Cancer Society (ACS) estimated that in 2018, approximately 1,735,350 new cancer cases were diagnosed. Targeted drug delivery system (TDDS) is a system, which delivers the drug in a controlled manner at a preselected biosite. Diabetes is a life-threatening chronic disease with no specialized cure. Diabetes of all types can lead to various complications in many parts of the body and can increase the overall risk of premature death. For instance, according to the International Diabetes Federation (IDF), in 2017, a number of people with diabetes in North America was approximately 46 million, which is expected to reach 62 million in 2045. Thus, the increasing number of patients suffering from one or more chronic diseases is expected to boost the growth of drug delivery devices market over the coming years.
The US drug delivery systems market is expected to grow at the highest rate during the forecast period. The growth of this market is primarily driven by increasing prevalence of chronic diseases like diabetes, asthma, and others, a growing number of product launches by key players; and increasing use of drug delivery systems for disease management. The market for drug delivery systems in the US region is expected to reach US$ 741,528.96 Mn in 2027 from US$ 388,359.24 Mn in 2018. The growth rate of the market in the region is estimated to be 7.6% during the forecast period.
North America Drug Delivery Systems Market Revenue and Forecasts to 2027 ( US$ Mn)
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
NORTH AMERICA DRUG DELIVERY SYSTEMS– MARKET SEGMENTATION
By Route of Administration
- Oral
- Solid Oral Drugs
- Liquid Oral Drugs
- Semi-solid Oral Drugs
- Transmucosal
- Pulmonary Drug Delivery
- In-metered Dose Inhalers
- Dry Powder Inhalers
- Nebulizers
- Nasal Drug Delivery
- Nasal Sprays
- Nasal Drops
- Nasal Gels
- Buccal Drug Delivery
- Sublingual Drug Delivery
- Rectal Transmucosal Drug delivery
- Vaginal Transmucosal Drug Delivery
- Pulmonary Drug Delivery
- Injectable
- Conventional Injection Devices
- Self-Injection Devices
- Needle Free Injectors
- Pen Injectors
- Wearable Injectors
- Topical
- Semi-solid Topical Drug Delivery Formulations
- Liquid Topical Drug Delivery Formulations
- Solid Topical Drug Delivery Formulations
- Transdermal Patches
- Transdermal Gels
- Others
- Implantable
- Active Implantable
- Passive Implantable
- Ocular
- Eye Drops & Sprays
- Gels & Ointments
- Ocular Inserts
- Drug Coated Contact Lenses
NORTH AMERICA DRUG DELIVERY SYSTEMS – MARKET SEGMENTATION
By Application
- Hospital & Clinics
- Home Care Settings
- Others
NORTH AMERICA DRUG DELIVERY SYSTEMS – MARKET SEGMENTATION
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Country
- U.S
- Canada
- Mexico
Companies Mentioned
- BD
- Novo Nordisk A/S
- 3M
- Boston Scientific Corporation
- Bausch Health Companies Inc.
- Baxter International, Inc.
- Boehringer Ingelheim
- Novartis AG
- GlaxoSmithKline plc.
- Johnson & Johnson Services, Inc.
North America Drug Delivery Systems Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 572,453.0 Million |
| Market Size by 2027 | US$ 1,074,679.7 Million |
| Global CAGR (2019 - 2027) | 7.4% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By Route of Administration
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
Market Research & Consulting
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
Yukihiko Adachi CEO, Deep Blue, LLC.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Strategic Planning
- Investment Justification
- Identifying Emerging Markets
- Enhancing Marketing Strategies
- Boosting Operational Efficiency
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.
The List of Companies - North America Drug Delivery Systems Market
1. BD 2. Novo Nordisk A/S 3. 3M4. Boston Scientific Corporation 5. Bausch Health Companies Inc. 6. Baxter International, Inc. 7. Boehringer Ingelheim 8. Novartis AG9. GlaxoSmithKline plc. 10. Johnson & Johnson Services, Inc.
Get Free Sample For